Cosmos Holdings Stock: Updates After Listing on Nasdaq

Since the end of February, shares of Cosmos Holdings (NASDAQ: COSM) are available for trading on the Nasdaq Stock Market.

Nasdaq Listing

Cosmos Holdings (COSM) raised $6 million in February after it up-listed to the Nasdaq Stock Market, reaching a “historic milestone” for the company.

The listing comes after Cosmos CEO Greg Siokas converted $6 million of debt the company owed him into common shares at $6 apiece. At the time, COSM stock price averaged $4-$5 and the conversion reinforced the company’s balance sheet. 

Although purchasing shares of your own company is an uncommon practice among company executives, it is typically viewed as a strong investment indicator. 

Shares closed nearly 3% higher on the Nasdaq debut and were up nearly 20% at one point of the day. Since then, COSM stock has moved lower to now trade at 18-month lows, or just around the $2 handle.

The international pharmaceutical company has a market cap of just over $35 million.

New Pharmaceutical Products

Cosmos Holdings recently announced the launch of Brainlit, a supplement for brain health developed by the company’s nutritional supplement proprietary line, Sky Premium Life. 

The company has created an innovative formula designed to improve brain function. The number of brain-related diseases such as dementia, Parkinson’s, and depression has increased over the past recent years. Still, there is a significant lack of effective treatments for these diseases. 

“With the global population aging, there is increased demand for high-quality brain health supplements that can enhance memory, improve brain function and health,” said Siokas.

A recent report by Fortune Business Insight showed that the Covid-19 pandemic has battered multiple global industries. Yet, it has also “presented a tremendous growth opportunity” in other sectors, including nutraceuticals.

Nutraceuticals are substances that have physiological benefits or provide protection against chronic diseases. Nutraceuticals may be used to improve health, delay the aging process, prevent chronic diseases, or support the body and mind.

The demand for health-boosting products skyrocketed following the pandemic outbreak. Fortune Business Insight predicts this market to grow from $352.9 billion in 2021 to $658.1 billion in 2028.

European analysts expect the nutraceuticals market to hit $108 billion by 2027, from its estimated worth of $59.3 billion in 2018. 

Furthermore, the researchers estimate the U.S. market at $104.5 billion in 2021 and expect the China market to hit $52.5 billion by 2026. Researchers claim that nutraceuticals represent a “vital link between health and food.”

COSM Business Expectations

Cosmos is looking to achieve 2022 revenue growth in the range of 15-20% to more than $65 million and a gross margin increase to 18%. 

The company also intends to launch 40 to 50 new sophisticated nutraceutical products, including the SPL Mediterranean Line expected in the second quarter of this year. 

Additionally, Cosmos plans to launch Amazon Stores in European countries including Italy, Germany, Spain, and France, as well as Singapore, Brazil, and the U.S. in the second half of the year. 

The company plans to introduce its SPL store on China’s largest cross-border B2C online marketplace, Tmall Global, this spring. 

In its outline of future plans, Cosmos said it wants to increase the management headcount. The company aims to support its aggressive growth strategy, add new board members, and set up an advisory board.

Cosmos also said it will focus on mergers and acquisitions (M&A) as well as joining venture (JV) deals. The company plans to strike strategic partnerships that will help expand its geographic footprint and market share, as well as increase operational efficiency and market penetration. 

Summary

Cosmos Holdings (COSM) shares are now available for trading on the Nasdaq Stock exchange. The listing will further increase the company’s transparency and provide investors with access to investing in a growing pharmaceutical company.

Want to see if we think Cosmos Holdings (COSM) is a good stock to buy? Learn more.

Beat The Market With Our Expert Stock Picks

If you invested in 10 of our featured stock picks over the last 5 years, your chances of beating the market would be 90%.

Our last 3 stock picks grew a combined 348% after our alert!

Want to be notified the next time we issue a “Big Buy” alert or update our stocks to buy list? Sign up below today.